Investors in biotech stocks were getting a little weary leading up to the Presidential elections. However, with the results in favor of Donald Trump, biotech stocks are trading higher.
Some of the stocks are gaining significantly in Wednesday's pre-market session. Clinton was not happy with drug pricing by pharmaceutical firms, and many feared of the price cuts and regulations her presidency might bring to the table.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
The following stocks gained in the pre-market trading on Wednesday:
- SPDR S&P Biotech (ETF) (NYSE: XBI) trading up 4.8 percent to $60.60
- iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) added 4.33 percent to $272.96.
- Valeant Pharmaceuticals Intl Inc (NYSE: VRX), which tanked 21.69 percent on Tuesday, gained 1.13 percent to $15.15.
- Mylan NV (NASDAQ: MYL) jumped 5.85 percent to $39.28.
- Pfizer Inc. (NYSE: PFE) advanced 7.33 percent to $32.25.
- Eli Lilly and Co (NYSE: LLY) gained 3.01 percent to $76.25.
- Amgen, Inc. (NASDAQ: AMGN) was up 2.82 percent to $142.35.
- Gilead Sciences, Inc. (NASDAQ: GILD) added 1.94 percent to $75.50.
- Merck & Co., Inc. (NYSE: MRK) gained 2.88 percent to $62.25.
- Novartis AG (ADR) (NYSE: NVS) advanced 2.41 percent to $73.00.